Celebrating partnerships to save more lives, sooner
Partners from across the life sciences sector came together to celebrate the progress of Canada’s Immuno-Engineering and Biomanufacturing Hub.
Launching Canada’s Immuno-Engineering and Biomanufacturing Hub
Leaders from across B.C.’s biotech sector gathered to launch a new national research hub led by UBC.
UBC faculty of medicine researchers receive federal support to advance mRNA vaccine technologies
$11.1 million will improve the delivery and efficacy of mRNA vaccines and boost B.C. biotechnology impact on the global stage.
New milestone toward universal blood type organs for transplant
Universal organs could be life-saving for patients on waitlists.
UBC Medicine spin-off company raises US$40m to advance drug discovery
Dr. Sriram Subramaniam is integrating cryo-electron microscopy and AI to bring new treatment options to patients.
New honours for UBC researchers highlight biomedical innovation golden age in B.C.
How UBC’s award-winning researchers are solving today’s most urgent health issues with new technologies.
UBC scientists first in the world to unveil molecular-level analysis of Omicron spike protein
Findings show strong antibody evasion and binding with human cells that contribute to increased transmissibility—and that vaccination remains the best defence.
Cancer chemotherapy drug reverses Alzheimer’s symptoms in mice
UBC researchers have found Axitinib can restore memory and cognitive function in mice.
Study finds new biomarker for a disease caused by bone marrow transplant
The discovery could lead to new ways to diagnose and treat the disease.
New study examines ‘Achilles’ heel’ of cancer tumours, paving the way for new treatment strategies
UBC and BC Cancer researchers have uncovered a weakness in a key enzyme that solid tumour cancer cells rely on to adapt and survive.